Health Solan

95 drug samples from Himachal Pradesh fail quality tests

The affected batches include children's syrups and heart medicines from pharmaceutical units in Solan, Sirmaur, and Una.

Key points

  • Between 93 and 95 drug samples from Himachal Pradesh failed quality tests, including heart medicines and children's syrups.
  • The Central Drugs Standard Control Organization issued the alert on October 24, 2026, covering units in Solan, Sirmaur, Una and other districts.
  • State Drug Controller Dr. Manish Kapoor has banned the sale of affected batches and issued show-cause notices to companies.

Between 93 and 95 drug samples from Himachal Pradesh failed quality tests, according to a monthly Drug Alert issued by the Central Drugs Standard Control Organization on October 24, 2026.

The failed samples include medicines for heart conditions, children's syrups, and treatments for fever, pain, cough, allergies, infections, and thyroid.

Samples from Solan, Sirmaur, and Una districts were found non-compliant. The alert includes pharmaceutical units in Baddi, Barotiwala, Nalagarh, Jhadmajari, Kalaamb, Paonta Sahib, Dawani, Gullarwal, and Kangra.

The Central Drugs Standard Control Organization reported that between 330 and 331 drug samples failed nationwide.

The failures were confirmed by lab testing conducted by the State Laboratory and Central Drugs Standard Control Organization. Issues identified include poor sterilization and low levels of active pharmaceutical ingredients.

The alert covers samples from over 30 pharmaceutical companies, including Ajot Life Sciences, Brit Life Sciences, Horizon, and Labo-Research.

State Drug Controller Dr. Manish Kapoor announced that legal action will be taken against the companies. Show-cause notices have been issued to the firms involved.

The sale and distribution of all affected batches have been banned.